Ajanta Pharma Launches Anti-Dementia Drug In US


Mumbai : Ajanta Pharma takes a step forward, Meanwhile Ajanta Pharma announced the launch of Memantine Hydrochloride Tablets in the US market. The company has launched it in 2 strengths 5mg & 10 mg tablets to address different levels of treatment. Ajanta Pharma Ltd is currently trading at Rs. 1588, up by Rs. 26.7 or 1.7% from its previous closing of Rs. 1561.2 on the BSE.

The scrip opened at Rs. 1568.2 and has touched a high and low of Rs. 1593 and Rs. 1560 respectively. The current market cap of the company is Rs. 13739.7 crore. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1720 on 12-Aug-2015 and a 52 week low of Rs. 1103 on 18-Jan-2016. Last one week high and low of the scrip stood at Rs. 1589.7 and Rs. 1531.2 respectively. The promoters holding in the company stood at 73.78 % while Institutions and Non-Institutions held 11.67 % and 14.55 % respectively.
The stock is currently trading above its 50 DMA.